INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "ANTI-GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR (GIPR) ANTIBODIES AND ANTIBODY CONJUGATES FOR THE TREATMENT OF METABOLIC DISORDERS"

GENEVA, May 27 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2024/061364) for "ANTI-GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR (GIPR) ANTIBODIES AND ANTIBODY CONJUGATES FOR THE TREATMENT OF METABOLIC DISORDERS" on Nov 14, 2024. With publication no. WO/2025/104668, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): APGAR, James Reasoner (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), DULLEA, Robert Gregory (c/o Pfizer Inc.610 Main StreetCambridge, Massach...